Investigation and Management of Chronic Lymphocytic Leukemia

More documents

Recommendations

Info

Patient Course 1. Treated with prednisone with resolution of his hemolytic anemia 2. Anemia recurred as prednisone reduced 3. Started on CRD chemotherapy and had excellent response
Incidence of immune cytopenias after FCR at MD Anderson 300 pts received FCR 19 (6.5%) develop immune cytopenias 2 red cell aplasia 17 AIHA (only 20% DAT+ve) Median, 4 cycles of FCR 5 of 19 after completion of FCR Borthakur et al. BJH, 136:800, 2007
Page 1 and 2: Investigation and Management of Chr
Page 3 and 4: Types of Lymphoproliferative Diseas
Page 5 and 6: Chronic B Cell Disorders & Flow Cyt
Page 7 and 8: Relevance of MBL? MBL 1%/year CLL L
Page 9 and 10: Anemia/Thrombocytopenia in CLL 24%
Page 11 and 12: Predicting Disease Progression Mark
Page 13 and 14: Other Investigations Routine bioch
Page 15 and 16: Approaches to Initial Treatment Amo
Page 17 and 18: CLL8 Study Design and Treatment Unt
Page 19 and 20: Adverse Events Total number of pati
Page 21 and 22: Progression-Free Survival Binet B/F
Page 23 and 24: Prognostic Markers Hallek et al. La
Page 25 and 26: Standard Treatments Reference Treat
Page 27 and 28: Complications of CLL Most deaths r
Page 29 and 30: Risk of AIHA with Chemotherapy 739
Page 31 and 32: What Rai Stage does he have? 1. Rai
Page 33 and 34: You would tell patient 1. “Don’
Page 35 and 36: You would order 1. Hemolytic anemia
Page 37 and 38: Significance of Direct Antiglobulin
Page 39 and 40: In 3 months CBC Lymphocytes 87 x
Page 41: Patient course Patient treated wit
Page 45 and 46: Survival Borthakur et al. BJH, 136:
Page 47 and 48: Case #2 56 yr of man has a routine
Page 49: Patient turns out to have a colon c

Investigation and Management of Chronic Lymphocytic Leukemia

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?